NFKB1 and metabolic disease: Remarkably, the outcomes underscored pronounced enrichment in Endocrine and metabolic disease signaling pathways, alongside photodynamic therapy‐induced NF‐κB survival signaling pathways, as delineated in Figure 2D,F, respectively.